UNSPSC 51373401: Ammonium/bromodiphenhydramine/codeine/menthol/potassium

This classification denotes a combination drug defined by the U.S. Department of Veterans Affairs in its (VA's) National Drug File (NDF), which falls under VA Drug Class RE301. This VA Drug Class (RE301) classifies this compound as belonging to the group OPIOID-CONTAINING ANTITUSSIVES/EXPECTORANTS.

UNSPSC 51373401 Ammonium/bromodiphenhydramine/codeine/menthol/potassium is a Commodity code covering pharmaceutical and over-the-counter products that state and local governments procure for health and public-safety programs. The recent activity shows state and local buyers sourcing naloxone and drug deactivation systems, as well as generic multi-source pharmaceuticals and OTC products through cooperative purchasing vehicles. Issuing bodies include county health departments (Seminole County, Florida) and state-level cooperative purchasing alliances administering pharmaceutical contracts on behalf of multiple participating jurisdictions. The work entails purchasing finished pharmaceutical products and related health supplies, managing wholesaler relationships and supply chains, and ensuring compliance with FDA requirements, cGMP certifications, and Drug Supply Chain Security Act (DSCSA) standards.

Recent activity spans Florida and the upper Midwest. Seminole County, Florida posted an IFB on June 30, 2026 (due July 26, 2023) for 1,900 units of naloxone and 800 safe drug deactivation systems annually with quarterly deliveries to its Community Health Building in Sanford. The Minnesota Multistate Cooperative Purchasing Alliance (MMCAP), administered by the Minnesota Department of Administration's Office of State Procurement, issued an RFP posted January 20, 2026 (due March 26, 2026) to establish multiple contracts for generic multi-source pharmaceuticals and OTC products for distribution across participating state and local government facilities, including Oregon. The MMCAP solicitation requires vendors to maintain relationships with authorized wholesalers (AmerisourceBergen Drug Corporation/Cencora, Cardinal Health, and Morris & Dickson Co., LLC), certify cGMP and DSCSA compliance, and accept a 3 percent administrative fee on all contract purchases with performance penalties for violations.